Investor Relations

Comments?

Please fill out our Feedback Form and let us know how you like our Investor website.

  


 

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on diagnostics, breast health, GYN surgical, and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts.

Hologic employs approximately 5,500 employees worldwide. The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol "HOLX".

Announcements

Wednesday, July 9, 2014
Hologic to Release Third Quarter Fiscal 2014 Operating Results on Wednesday, July 30, 2014

Read Release

Tuesday, June 24, 2014
3D Mammography Significantly Increases the Detection of Breast Cancer Concludes a Study that Reviewed Close to Half a Million Exams Published in the Journal of the American Medical Association (JAMA)
Read Release
 

Wednesday June 11, 2014
Premier, Inc. Selects Two Hologic 3D Mammography Products as Breakthrough Technologies at Sixth Annual Innovation Celebration
Read Release

 

Wednesday, June 4, 2014
Hologic to Present at the Goldman Sachs 35th Annual Global Healthcare Conference
Read Release
Listen to Webcast

 

Thursday, May 15, 2014
Hologic's New Tomcat Pre-analytical Sample Processing Instrument to be Featured at the American Society for Microbiology General Meeting
Read Release

 

Tuesday, May 13, 2014
Hologic Names Robert W. McMahon Chief Financial Officer
Read Release
 

Wednesday, April 30, 2014
Hologic Announces Second Quarter Fiscal 2014 Operating Results
Read Release
View Presentation

 

Wednesday, April 23, 2014
Hologic Highlights Its World-class Portfolio of Healthcare Solutions for Women at ACOG, the Premier OB/GYN Clinical Conference
Read Release

Tuesday, April 22, 2014

Hologic’s NovaSure System Reaches a Significant Milestone: Over Two Million Women Have Chosen the NovaSure Procedure to Address the Problem of Heavy Periods
Read Release
 

Wednesday, April 9, 2014
Hologic to Release Second Quarter Fiscal 2014 Operating Results on Wednesday, April 30, 2014
Read Release
Listen to Webcast